All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 10 out of 2191 results
|
News Release
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug...
|
Research Feature
pulmonaryhypertension.jpg
Pulmonary hypertension is a disease in which pressure rises in the arteries that carry oxygen-poor blood from the heart to the lungs. Symptoms include shortness of breath during light physical activity (for example, climbing a flight of stairs), tiredness, chest pain, and a racing heartbeat. As...